MARKET

NPCE

NPCE

Neuropace Inc
NASDAQ
15.79
-0.02
-0.13%
After Hours: 15.83 +0.04 +0.25% 18:51 05/14 EDT
OPEN
16.04
PREV CLOSE
15.81
HIGH
16.48
LOW
15.57
VOLUME
123.75K
TURNOVER
--
52 WEEK HIGH
19.60
52 WEEK LOW
7.56
MARKET CAP
538.34M
P/E (TTM)
-24.0701
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), NeuroPace (NPCE) and Avalo Therapeutics (AVTX)
TipRanks · 18h ago
Neuropace Warns Cybersecurity Threats to Intracranial EEG Data Could Hit Operations, Reputation and Growth
TipRanks · 22h ago
NeuroPace Earnings Call Highlights RNS Growth Momentum
TipRanks · 1d ago
NeuroPace (NPCE) Receives a Buy from Lake Street
TipRanks · 1d ago
NeuroPace: Buy Rating Reiterated on Raised Guidance, Differentiated RNS Platform, and Attractive $20 Price Target Versus High-Growth Med-Tech Peers
TipRanks · 1d ago
Neuropace signals $99M-$101M 2026 revenue outlook while targeting 21%-23% underlying RNS growth
Seeking Alpha · 2d ago
NeuroPace Reports Q1 2026 Results: Full Earnings Call Transcript
Benzinga · 2d ago
NeuroPace reports Q1 EPS (20c), consensus (23c)
TipRanks · 2d ago
More
About NPCE
NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.

Webull offers Neuropace Inc stock information, including NASDAQ: NPCE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NPCE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NPCE stock methods without spending real money on the virtual paper trading platform.